All Type of News
Korea finds increase in share of clinical trials despite decrease in the world
Despite the trend where the number of trials is decreasing around the world, Korean pharmaceutical companies have reportedly conducted more clinical trials.
The Korea National Enterprise for Clinical Trials(KoNECT) ...
How to check if I’m taking antihypertensive drugs containing suspended Valsartan ingredients?
If you would like to see if the Valsartan antihypertensive you are taking is suspended in sales, you can simply visit the Health Insurance Review & Assessment Service’s(HIRA) website.
If you find out you have taken ...
Drug price cuts will also be executed on orphan drugs and shortage-prevented medicines
Orphan drugs and shortage-prevented medicines will also get drug price cuts for illegal rebates.
The Ministry of Health and Welfare(MOHW) will pre-announced the ‘Partial Revision Bill to the National Health Insuranc...
Last year, quasi drugs manufactured KRW 1.4 trillion with decrease for first time in 5 years
Quasi drugs were manufactured for KRW 1.4703 trillion last year in Korea, decreased by 24.5% compared to the year before.
The Ministry of Food and Drug Safety(Minister Young-Jin Ryu) analyzed and announced the ‘2017...
New bill to eradicate hospitals owned by unlicensed doctors, imposing 10-year imprisonment or KRW 100 billion fine
A bill will be carried out to strengthen punishment on hospitals owned by unlicensed doctors with less than 10 years of prison or a less than KRW 100 million fine.
Party for Democracy and Peace Rep. Jung-Bae Chun re...
KPA asks KMA to stop blaming on pharmacists over Valsartan incident
As the antihypertensive drug containing Chinse Valsartan ingredients with carcinogenic substances has become a huge issue, it has led to a conflict over capability between doctors and pharmacists unintentionally.
Th...
Pharma distribution industry getting close to critical point in drug return
The amount of returned products is reaching the critical point in storages pharmaceutical distribution companies own. These distribution companies are expanding their storages specially for returned products, and the ...
“We’ll quickly reveal risk evaluation result on Chinese Valsartan”
The Ministry of Food and Drug Safety(MFDS) has already created a bill to evaluate N-Nitrosodimethylamine(NDMA) in antihypertensives with Chinese Valsartan, and was planning to reveal the evaluation result soon.
The ...
Government to create 300 ventures and 1,000 job positions using H+OIC
The ‘Healthcare Open Innovation Committee’ which will establish bio-health ecosystem will start carrying out affairs to achieve the goal to make 300 ventures and 1,000 job positions.
The Ministry of Health and Welfa...
Pharmaceutical companies still strong in quasi drug market for 4 years
For the past 4 years, a pharmaceutical company made the top sales in the quasi drug field, and showed consecutive increases in the amount manufactured.
On the 13th, Yakup Shinmoon(www.yakup.com) summarized and analyz...
